Related Experiment Video
Updated: Jul 16, 2026
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
Somatostatin binding in human gastrointestinal tissues: effect of cations and somatostatin analogues
G V Miller1, S R Preston, L F Woodhouse
1Academic Surgical Unit, St James's University Hospital Trust, Leeds.
Abstract:
This study characterises the somatostatin binding site in human gastrointestinal cancer and mucosa in terms of cationic specificity and relative affinity for three somatostatin analogues. Competitive displacement assays were performed on plasma membranes from human gastric and colonic tissues using radiolabelled somatostatin-14 as ligand. Comparison was made with the somatostatin binding site in rat cerebral cortex. In gastrointestinal tissue, magnesium decreased and sodium increased specific binding. By contrast, in rat cerebral cortex, the converse cationic effect was seen. These changes resulted from alterations in receptor density, with no change in receptor affinity. Displacement studies were then performed with somatostatin-14 and somatostatin analogues RC-160, somatuline, and octreotide. RC-160 and somatuline displaced radiolabel from binding sites in gastric and colonic cancer and mucosa with 10-fold lower affinity than the native peptide. Octreotide did not displace radioligand in gastric or colonic cancer at any concentration tested. By contrast, in rat cortex, although all three analogues displaced with a lower affinity than the native peptide, there was no difference between analogues. These data suggest a distinct somatostatin receptor subtype in gastrointestinal tissues.
Insights
Researchers identified a unique somatostatin receptor subtype in human gastrointestinal tissues. This finding differs from rat brain receptors and impacts how somatostatin analogues bind to cancer cells.
Area of Science:
- Endocrinology
- Gastroenterology
- Oncology
Background:
- Somatostatin receptors play a crucial role in regulating various physiological processes.
- Understanding somatostatin receptor subtypes is vital for developing targeted therapies, particularly in gastrointestinal cancers.
- Previous research has characterized somatostatin binding sites, but specific details in human gastrointestinal tissues remain less understood.
Purpose of the Study:
- To characterize the somatostatin binding site in human gastrointestinal cancer and mucosa.
- To determine the cationic specificity and relative affinities of three somatostatin analogues (RC-160, somatuline, octreotide) for these binding sites.
- To compare the binding characteristics with those found in the rat cerebral cortex.
Main Methods:
- Competitive displacement assays were conducted on plasma membranes from human gastric and colonic tissues.
- Radiolabeled somatostatin-14 was used as the primary ligand.
- The effects of magnesium and sodium ions on binding were assessed, alongside displacement studies with somatostatin analogues.
Main Results:
- In gastrointestinal tissues, magnesium decreased and sodium increased specific somatostatin binding, attributed to altered receptor density.
- RC-160 and somatuline showed 10-fold lower affinity than somatostatin-14 in gastrointestinal tissues, while octreotide showed no displacement.
- Rat cerebral cortex exhibited converse cationic effects and no differential affinity among the tested somatostatin analogues.
Conclusions:
- The study suggests the presence of a distinct somatostatin receptor subtype in human gastrointestinal tissues.
- This receptor subtype exhibits unique cationic specificities and differential affinities for somatostatin analogues compared to the rat cerebral cortex.
- These findings have implications for the development of novel therapeutic strategies targeting somatostatin receptors in gastrointestinal malignancies.
Related Concept Videos
01:50What is Monogastric Digestion?
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
01:25Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples: